Research Paper Volume 12, Issue 2 pp 1213—1236
MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma
Figure 5. miR-200a impaired anti-tumor immunity in vivo. (A–B) Flow cytometry analysis of intratumoral proportion of CD4+ and CD8+ T cells. (C–D) Flow cytometry analysis of intratumoral proportion of Foxp3+ Treg cells. (E–F) Flow cytometry analysis of intratumoral proportion of IFN-γ+ CTLs. *P<0.05, **P<0.01, ***P<0.001.